1,371 results on '"Cucchiara, Salvatore"'
Search Results
2. Management of collagenous gastritis in children: Case series and literature review
3. PARP1 inactivation increases regulatory T / Th17 cell proportion in intestinal inflammation. Role of HMGB1
4. Clinical Trials (Clinical Perspective)
5. Infectious Esophagitis
6. Crohn’s Disease
7. Microbiome signatures of progression toward celiac disease onset in at-risk children in a longitudinal prospective cohort study
8. Whether and when to biopsy coeliac patients: A never-ending story
9. A new double immunohistochemistry method to detect mucosal anti-transglutaminase IgA deposits in coeliac children
10. Efficacy and Safety of a new Low-Volume PEG with Citrate and Simethicone bowel preparation for pediatric elective colonoscopy: a phase 3 RCT
11. Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study
12. Gastrointestinal endoscopy in children and adults: How do they differ?
13. Infectious Esophagitis
14. Crohn’s Disease
15. Evaluation of Risk for Thromboembolic Events in Pediatric Inflammatory Bowel Disease
16. Transition of inflammatory bowel disease patients from pediatric to adult care: an observational study on a joint-visits approach
17. Functional analysis of gut microbiota and immunoinflammation in children with autism spectrum disorders
18. A Treat to Target Strategy Using Panenteric Capsule Endoscopy in Pediatric Patients With Crohn’s Disease
19. Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)
20. Fecal and mucosal microbiota profiling in pediatric inflammatory bowel diseases
21. Diagnostic Value of Persistently Low Positive TGA-IgA Titers in Symptomatic Children With Suspected Celiac Disease
22. Safety of Oats in Children with Celiac Disease: A Double-Blind, Randomized, Placebo-Controlled Trial
23. MRI reveals different Crohn’s disease phenotypes in children and adults
24. A 12-Week Maintenance Therapy with a New Prepared Viscous Budesonide in Pediatric Eosinophilic Esophagitis
25. Multi-omics analysis reveals the influence of genetic and environmental risk factors on developing gut microbiota in infants at risk of celiac disease
26. RIP3 AND pMLKL promote necroptosis-induced inflammation and alter membrane permeability in intestinal epithelial cells
27. PARP1 Activation Induces HMGB1 Secretion Promoting Intestinal Inflammation in Mice and Human Intestinal Organoids
28. ESPGHAN ‘biopsy-sparing’ guidelines for celiac disease in children with low antitransglutaminase during COVID-19
29. Infectious Esophagitis
30. Crohn’s Disease
31. Pediatric Celiac Disease: Follow-Up in the Spotlight
32. Intestinal Inflammation Alters the Expression of Hepatic Bile Acid Receptors Causing Liver Impairment
33. Barium Studies
34. Aortic, carotid intima-media thickness and flow- mediated dilation as markers of early atherosclerosis in a cohort of pediatric patients with rheumatic diseases
35. Celiac disease in a large cohort of children and adolescents with recurrent headache: A retrospective study
36. Krill oil reduces intestinal inflammation by improving epithelial integrity and impairing adherent-invasive Escherichia coli pathogenicity
37. Endoscopy in Pediatric Inflammatory Bowel Disease: A Position Paper on Behalf of the Porto IBD Group of the Espghan
38. Anaphylaxis after wheat ingestion in a patient with coeliac disease: two kinds of reactions and the same culprit food
39. Predictors of Long-term Clinical and Endoscopic Remission in Children With Crohn Disease Treated With Infliximab
40. Managing paediatric acute severe ulcerative colitis according to the 2011 ECCO-ESPGHAN guidelines: Efficacy of infliximab as a rescue therapy
41. Natural history of pancreatic involvement in paediatric inflammatory bowel disease
42. Gelatin Tannate for Acute Childhood Gastroenteritis: A Randomized, Single-Blind Controlled Trial
43. NOD2 induces autophagy to control AIEC bacteria infectiveness in intestinal epithelial cells
44. Clinical Trials (Clinician Perspective)
45. Narrow band imaging combined with water immersion technique in the diagnosis of celiac disease
46. Use of biosimilars in inflammatory bowel disease: Statements of the Italian Group for Inflammatory Bowel Disease
47. Clinical Trials (Clinical Perspective)
48. ZNF281 Promotes Colon Fibroblast Activation in TGFβ1-Induced Gut Fibrosis
49. Proteomic Analysis Identifies Three Reliable Biomarkers of Intestinal Inflammation in the Stools of Patients With Inflammatory Bowel Disease
50. Colonic inflammation accelerates the progression of liver disease: A protective role of dipotassium glycyrrhizate
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.